Brief: China Resources Pharmaceutical Says Proposed Increase Of Registered Capital By CR Pharma Commercial
Dec 29 (Reuters) - China Resources Pharmaceutical
3320.HK :
* PROPOSED INCREASE OF REGISTERED CAPITAL- BY CR
PHARMACEUTICAL
COMMERCIAL
* CR PHARMACEUTICAL COMMERCIAL ENTERED INTO SUBSCRIPTION
AGREEMENT
WITH BEIJING PHARMACEUTICAL, AMONG OTHERS
* CR PHARMACEUTICAL COMMERCIAL TO INCREASE ITS REGISTERED
CAPITAL
FROM RMB15 BILLION TO RMB19.65 BILLION
* INVESTOR SUBSCRIBERS TO SUBSCRIBE FOR INCREASED REGISTERED
CAPITAL OF RMB3.90 BILLION FOR RMB5.26 BILLION
Further company coverage: 3320.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on China Resources Pharmaceutical
See all newsBrief: China Resources Pharmaceutical Group Declares Interim Dividend Of RMB0.087 Per Share
Brief: China Resources Pharmaceutical Says Tasly Pharmaceutical Posts HY Net Profit Attributable Of RMB 892.7 MLN
Brief: China Resources Pharmaceutical Group Says HY Revenue RMB 1.93 Billion For CR Jiangzhong
Brief: China Resources Pharmaceutical Group Posts HY Revenue RMB 1.64 Billion, Down 50.97% For KPC Pharmaceuticals
Brief: China Resources Pharmaceutical Says CR Boya Bio-Pharmaceutical Posts Quarterly Unaudited Revenue RMB 321.1 Million, Net Profit RMB 30.0 Million